FDA Drug Recalls

Recalls / Class II

Class IID-66403-004

Product

Ciprofloxacin Tablets, USP, 250 mg, 100-count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7097-01

Affected lot / code info
Lot #: 3032075, 3032076

Why it was recalled

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Recalling firm

Firm
Mylan Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
781 Chestnut Ridge Rd, N/A, Morgantown, West Virginia 26505-2730

Distribution

Quantity
521 bottles
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2013-09-13
FDA classified
2013-11-04
Posted by FDA
2013-11-13
Terminated
2015-07-23
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-66403-004. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls